FEBS Letters · 1996 · 39 citations · 12 references
Life SciencesBiochemistryPharmacologyApoptosisCancer PharmacologyMolecular PharmacologyApoptosis RegulationApoptotic Signal TransductionApoptotic SignalingCell DeathReceptor Tyrosine Kinase SignalingTyrosine Kinase InhibitorsAnti-apoptotic AgentsApoptosis In Cell CultureApoptosis Regulation By KinasesApoptosis-related Kinase CascadesDrug-induced ApoptosisProtein Tyrosine PhosphorylationTherapeutic Tyrosine Kinase InhibitorsTyrosine Phosphorylation Signaling
Didemnin B induces rapid apoptosis in human promyeloid HL-60 cells with an optimal concentration of 1 microM (Grubb et al. (1995) Biochem. Biophys. Res. Commum. 215, 1130-1136), but little is known about how it does so. In order to determine whether protein tyrosine phosphorylation is involved in this rapid induction of apoptosis, HL-60 cells were pre-treated with tyrosine kinase inhibitors for 1 h before didemnin B treatment. Genistein, 2,5-dihydroxycinnamic acid methyl ester, and a range of tyrphostins inhibit didemnin B-induced apoptotic morphology in a concentration-dependent manner. DNA fragmentation induced by didemnin B is also inhibited by genistein, 2,5-dihydroxycinnamic acid methyl ester, and tyrphostins.
12
Genistein, a specific inhibitor of tyrosine-specific protein kinases.
Tetsu Akiyama, Junko Ishida, Shizue Nakagawa et al. · Journal of Biological Chemistry · 1987 · 3.7K citations · Full text
David W. Montgomery, Charles F. Zukoski · Transplantation · 1985 · 87 citations
Inhibitors of tyrosine phosphorylation induce apoptosis in human leukemic cell lines.
Gaetano Bergamaschi, Vittorio Rosti, Marco Danova et al. · PubMed · 1993 · 86 citations